1800 244 735

Research articles

Click on this link to read our latest research articles.

Click on this link to find out more about Huntington’s NSW ACT Research grant opportunities.

HD Buzz

HDBuzz is a collaboration of scientists who write Huntington’s disease research news in plain language for the global HD community. They have allowed us to retrieve their articles for the NSW ACT Huntington’s community.

Westmead HD Outreach Service

The Outreach Service is part of a multidisciplinary team of medical, nursing and allied health services which provides review, intervention, treatment, case management, counselling, support, education and management of problems and issues associated with Huntington’s for patients, their families and carers. In addition to this care, the service has been involved in local and major international research studies since its establishment at Westmead Hospital in 1995. Hundreds of volunteers have generously participated in research to better understand the disease and in the search for effective treatments.

Westmead Hospital is a HSG Credential Research Site. Professor Clement Loy is the Principal Investigator for this site.

Global research collaboration

The Huntington Study Group (HSG) is the world’s first HD cooperative therapeutic research organization. Today, HSG is a world leader in facilitating high quality clinical research trials and studies that bring us closer to finding more effective treatments for HD and reducing the burden of HD for families affected by the disease.

HSG is an organization of compassionate professionals dedicated to finding treatments that make a difference, providing rigorous care initiatives, and improving the quality of life and outcomes for HD families. They bring together families, medical professionals, clinical researchers, HD advocacy groups, and sponsors to raise awareness of HD, share knowledge and best practices, and develop innovative treatments.

Enroll-HD

Enroll-HD is a clinical research platform and the world’s largest observational study for Huntington’s disease families. It is a resource for the entire HD community, including families, clinicians, researchers, advocates, and anyone else who has a connection to or an interest in HD.

Huntington’s Disease Network of Australia

The Huntington’s Disease Network of Australia (HDNA) is a project conceived by Professor Julie Stout of Monash University. Formed in 2020 to coordinate efforts that enhance care and services for HD and prepare for the advent of new HD treatments. The Map-HD Registry is for people in Australia who are affected by HD. All family members or people affected by HD are encouraged to register, whether or not they are at risk themselves.
 
 

          Huntington's Disease Network of Australia

EuroBuzz News: Day 1

Published date: 14 September, 2012

Our first daily report from the European Huntington’s Disease Network Meeting in Stockholm. Follow us live for the second day on Twitter or Facebook at HDBuzzFeed. Video of the day’s live Euro Buzz session – with news, interviews and features – will be available to watch on HDBuzz.net soon. Friday, September 14, 2012 8:11 – ... Read more

Coming Soon: EuroBuzz 2012

Published date: 10 September, 2012

Stand by for EuroBuzz – hot-off-the-press Huntington’s disease research news from the European HD Network Meeting in Stockholm, brought to you by HDBuzz. EHDN 2012 The European Huntington’s Disease Network (EHDN) is a Europe-wide collaboration of HD professionals, researchers and people affected by HD. EHDN exists to encourage sharing information and ideas about HD, studies ... Read more

Lithium with a twist gets second chance for HD

Published date: 2 September, 2012

Lithium treatment of Huntington’s disease is given a second chance, as new, safer dosing methods enter the drug development pipeline. Will long-term treatment with an old therapeutic be capable of preventing or slowing neurodegeneration in HD patients? A brief history of lithium Lithium is a soft, silver-white metal. As one of earth’s natural elements, it ... Read more

High-power brain scans reveal sodium changes in HD

Published date: 22 August, 2012

Using a new brain scanning technique for the first time in HD, researchers have found that people with Huntington’s disease may have increased sodium levels in their brains. But what does increased sodium actually mean? Why do we have sodium in our brains at all – isn’t it just salt? And why might a ‘salty ... Read more

Mapping the neighborhood: huntingtin's new protein partners

Published date: 13 August, 2012

Why haven’t we cured Huntington’s disease yet? One reason is that after twenty years of study, scientists still don’t understand what the huge Huntingtin protein – mutated in HD patients – does. In a new study, the group of William Yang at UCLA has mapped the ‘neighborhood’ of huntingtin to try and bring some clarity ... Read more

Does the HD mutation affect children's growth?

Published date: 7 August, 2012

The huntingtin gene and protein are active throughout our bodies, and weight loss is a well-known problem once symptoms of Huntington’s disease begin. Yet for many years, people with the mutation that causes HD, look and feel the same as people without it. Now a small study suggests that children carrying the HD mutation may ... Read more

'Induced' stem cells make exciting advances

Published date: 6 July, 2012

Stem cells are a source of great excitement for patients suffering from illnesses caused by the death of cells in the body – like Huntington’s disease. But the devil is in the details, and actually using these powerful cells to help HD patients is a complex problem. Now, two new studies have advanced stem cells ... Read more

ASO gene silencing reaches further, lasts longer

Published date: 21 June, 2012

Drugs called anti-sense oligonucleotides, or ASOs, are one way of silencing the gene that causes Huntington’s disease. A new publication in the journal Neuron suggests that ASO gene silencing reaches further in the brain than other methods, lasts longer and is safe. We have been waiting eagerly for developments in the field of gene silencing, ... Read more

Phosphodiesterase inhibitors: new HD drugs entering trials soon

Published date: 7 June, 2012

At this year’s HD therapeutics conference, Pfizer Pharmaceuticals and the CHDI Foundation announced big plans for new HD drugs that target something called ‘phosphodiesterases’. What’s so exciting about these new drugs, and what’s the timeline for bringing them to people? Phospho-di-what? Most people have probably heard of the drug Viagra. However, many would be surprised ... Read more

Interview: CHDI's scientific team

Published date: 18 May, 2012

The 2012 Huntington’s Disease Therapeutics Conference brought a hefty dose of news, excitement and optimism for people desperately waiting for effective treatments for HD. HDBuzz interviewed some of the leading scientific minds behind the Conference’s organizer, CHDI Foundation, Inc. What is CHDI? It’s a continuous source of surprise to us that many people from HD-affected ... Read more